To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MAPK12andHDAC10TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
543 supporting clones for gene MAPK12andHDAC10 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_032019.5   .a 1 to 2704 1 to 2704 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 2704/2704
(100 %)
0 diff
(100 %id)
AF426160   .a 21 to 2440 1 to 2420 exact tiling clone,   2420/2420
(100 %)
0 diff
(100 %id)
CR625146 Neuroblastoma Cot 25-normalized .a 169 to 2448 1 to 2280 exact     2280/2280
(100 %)
0 diff
(100 %id)
BX341750   .a 179 to 1190 1 to 1007       1007/1007
(100 %)
10 diff
(99.1 %id)
BC032049 Skin, normal .a 188 to 2448 1 to 2261 V429I available from MGC,   2261/2261
(100 %)
2 diff
(100.0 %id)
CR456465   .a 318 to 2420 1 to 2103 exact     2103/2103
(100 %)
0 diff
(100 %id)
BC125083 PCR rescued clones .a 327 to 2485 1 to 2159 exact tiling clone,   2159/2159
(100 %)
0 diff
(100 %id)
CU013303 Synthetic constructs .a 372 to 2384 18 to 2030 exact     2013/2041
(98 %)
9 diff
(99.6 %id)
CU013015 Synthetic constructs .a 372 to 2383 18 to 2029 exact     2012/2044
(98 %)
7 diff
(99.7 %id)
AF393962   .a 374 to 2383 1 to 2010 exact     2010/2010
(100 %)
0 diff
(100 %id)
AF407272   .a 374 to 2383 1 to 2010 A594T     2010/2010
(100 %)
2 diff
(100.0 %id)
CD633511   .a 414 to 1227 819 to 1       819/823
(99 %)
13 diff
(98.5 %id)
BU944817 adenocarcinoma, cell line, breast .a 416 to 1239 1 to 831       831/950
(87 %)
12 diff
(98.8 %id)
CN301618 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 710 to 1357 1 to 646       646/646
(100 %)
7 diff
(99.0 %id)
BM717754 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 846 to 1433 1 to 588       588/588
(100 %)
0 diff
(100 %id)
BX325522   .a 877 to 1789 21 to 923       903/923
(97 %)
31 diff
(96.7 %id)
BX368617 Neuroblastoma Cot 25-normalized .a 934 to 1708 1 to 775       775/865
(89 %)
18 diff
(98.0 %id)
BG470310 adenocarcinoma cell line, colon .a 990 to 1772 1 to 787       785/791
(99 %)
22 diff
(97.3 %id)
BQ648766 hepatocellular carcinoma, cell line, Liver .a 1020 to 1706 72 to 770       699/1125
(62 %)
26 diff
(97.7 %id)
BQ645690 hepatocellular carcinoma, cell line, Liver .a 1020 to 1795 11 to 793       783/985
(79 %)
21 diff
(97.9 %id)
BQ645889 hepatocellular carcinoma, cell line, Liver .a 1020 to 1792 10 to 799       790/936
(84 %)
21 diff
(97.8 %id)
BQ650761 hepatocellular carcinoma, cell line, Liver .a 1020 to 1692 73 to 751       679/1061
(63 %)
25 diff
(97.7 %id)
BQ644347 hepatocellular carcinoma, cell line, Liver .a 1020 to 1855 8 to 857       847/857
(98 %)
27 diff
(96.9 %id)
BQ650746 hepatocellular carcinoma, cell line, Liver .a 1020 to 1889 16 to 892       877/931
(94 %)
24 diff
(97.5 %id)
BQ654202 hepatocellular carcinoma, cell line, Liver .a 1020 to 1883 8 to 877       870/889
(97 %)
21 diff
(97.7 %id)
BI252356 hepatocellular carcinoma, cell line, Liver .a 1021 to 1793 1 to 771       771/771
(100 %)
15 diff
(98.1 %id)
BQ643658 hepatocellular carcinoma, cell line, Liver .a 1021 to 1882 1 to 864       864/864
(100 %)
4 diff
(99.6 %id)
BQ064495 lymph, lymphoma, cell line .a 1023 to 1893 1 to 874       874/980
(89 %)
12 diff
(98.8 %id)
BU196132 hepatocellular carcinoma, cell line, Liver .a 1023 to 1708 1 to 690       690/1167
(59 %)
14 diff
(98.9 %id)
BQ647318 hepatocellular carcinoma, cell line, Liver .a 1023 to 1596 1 to 575       575/1015
(56 %)
11 diff
(99.0 %id)
BQ648856 hepatocellular carcinoma, cell line, Liver .a 1023 to 1659 1 to 638       638/1026
(62 %)
8 diff
(99.3 %id)
BQ648820 hepatocellular carcinoma, cell line, Liver .a 1023 to 1708 1 to 686       686/949
(72 %)
16 diff
(98.4 %id)
BQ648735 hepatocellular carcinoma, cell line, Liver .a 1023 to 1911 1 to 892       890/893
(99 %)
7 diff
(99.3 %id)
BQ644708 hepatocellular carcinoma, cell line, Liver .a 1023 to 1853 1 to 836       836/957
(87 %)
18 diff
(98.2 %id)
BQ644912 hepatocellular carcinoma, cell line, Liver .a 1023 to 1591 1 to 575       575/1153
(49 %)
17 diff
(98.6 %id)
BQ649456 hepatocellular carcinoma, cell line, Liver .a 1023 to 1711 1 to 690       690/952
(72 %)
6 diff
(99.4 %id)
BQ651095 hepatocellular carcinoma, cell line, Liver .a 1023 to 1672 1 to 650       650/915
(71 %)
25 diff
(97.3 %id)
BQ651380 hepatocellular carcinoma, cell line, Liver .a 1023 to 1889 1 to 869       869/959
(90 %)
17 diff
(98.3 %id)
BI253026 hepatocellular carcinoma, cell line, Liver .a 2197 to 2622 437 to 4   tiling clone,   434/447
(97 %)
9 diff
(98.0 %id)
NM_001159286.1   .b 1 to 2644 1 to 2644 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 2644/2644
(100 %)
0 diff
(100 %id)
DN999048 bone marrow .b 31 to 598 81 to 648   tiling clone,   568/648
(87 %)
6 diff
(99.1 %id)
BX328541 Neuroblastoma Cot 25-normalized .b 62 to 868 1 to 807       807/845
(95 %)
35 diff
(95.9 %id)
BX354471 Neuroblastoma Cot 25-normalized .b 62 to 988 1 to 925       925/925
(100 %)
11 diff
(98.9 %id)
BX394158 Neuroblastoma Cot 25-normalized .b 149 to 812 1 to 665       665/680
(97 %)
9 diff
(98.7 %id)
BX328664 Placenta Cot 25-normalized .b 162 to 1065 1 to 904       902/963
(93 %)
17 diff
(98.3 %id)
BX349853   .b 166 to 1129 1 to 956       956/956
(100 %)
11 diff
(98.9 %id)
BX363893   .b 166 to 1147 1 to 976       974/1030
(94 %)
25 diff
(97.6 %id)
BM922933 leukocyte .b 167 to 1065 1 to 909       909/1087
(83 %)
29 diff
(97.4 %id)
BX376276 Neuroblastoma Cot 25-normalized .b 169 to 1129 1 to 947   tiling clone,   947/947
(100 %)
16 diff
(98.4 %id)
CD633510   .b 174 to 973 1 to 800       800/800
(100 %)
8 diff
(99.0 %id)
BM921032 pooled brain, lung, testis .b 174 to 1130 18 to 982   tiling clone,   965/1008
(95 %)
22 diff
(97.9 %id)
BI490004 pooled brain, lung, testis .b 175 to 249 1 to 75       75/75
(100 %)
0 diff
(100 %id)
BX328876   .b 179 to 1098 1 to 919       919/919
(100 %)
8 diff
(99.2 %id)
BU856160 ovary, teratocarcinoma, cell line .b 185 to 755 42 to 618       577/1056
(54 %)
24 diff
(97.8 %id)
BG742762 skin .b 188 to 932 1 to 743   available from MGC,   743/743
(100 %)
5 diff
(99.4 %id)
TI_57168290   .b 191 to 920 26 to 772       747/772
(96 %)
23 diff
(97.1 %id)
BI834705 pooled pancreas and spleen .b 197 to 920 1 to 741       741/741
(100 %)
26 diff
(96.5 %id)
BX389302 Placenta Cot 25-normalized .b 235 to 642 1 to 407       407/407
(100 %)
24 diff
(94.2 %id)
AF407273   .b 374 to 2323 1 to 1950 A574T tiling clone,   1950/1950
(100 %)
2 diff
(99.9 %id)
BU539726 adenocarcinoma, cell line, breast .b 415 to 934 63 to 585       523/1370
(38 %)
16 diff
(98.9 %id)
BI551915 brain, hippocampus .b 908 to 2234 1 to 872       870/872
(99 %)
47 diff
(94.7 %id)
TI_44171627   .b 1394 to 2234 89 to 956       865/956
(90 %)
48 diff
(95.0 %id)
AA485538 ovarian tumor, ovary .b 1431 to 1824 8 to 400       393/400
(98 %)
7 diff
(98.3 %id)
H74053 liver and spleen .b 1510 to 1757 1 to 247       247/247
(100 %)
2 diff
(99.2 %id)
BX328558 Neuroblastoma Cot 25-normalized .b 1552 to 2388 833 to 1       833/842
(98 %)
21 diff
(97.6 %id)
BX349816   .b 1572 to 2388 816 to 1       816/823
(99 %)
11 diff
(98.7 %id)
BX349852   .b 1573 to 2388 818 to 1       818/818
(100 %)
19 diff
(97.7 %id)
BQ231770 large cell carcinoma, lung .b 1578 to 2380 1 to 803       803/803
(100 %)
1 diff
(99.9 %id)
BI767281 pooled lung and spleen .b 1587 to 2379 1 to 795       795/795
(100 %)
15 diff
(98.2 %id)
TI_57181386   .b 1587 to 2388 1 to 803       803/866
(92 %)
18 diff
(98.0 %id)
BM849986 stomach .b 1593 to 2204 1 to 612       612/612
(100 %)
2 diff
(99.7 %id)
BX391473   .b 1602 to 2388 788 to 1       788/791
(99 %)
5 diff
(99.4 %id)
CD633508   .b 1611 to 2251 13 to 652       640/655
(97 %)
13 diff
(98.1 %id)
BX346426 Neuroblastoma Cot 25-normalized .b 1648 to 2388 740 to 1       740/925
(80 %)
9 diff
(99.1 %id)
BX391347 Placenta Cot 25-normalized .b 1648 to 2388 740 to 1       740/831
(89 %)
9 diff
(99.0 %id)
BX370913 Neuroblastoma Cot 25-normalized .b 1649 to 2388 743 to 1       743/850
(87 %)
17 diff
(98.0 %id)
BX349505 Neuroblastoma Cot 25-normalized .b 1650 to 2388 742 to 1       742/810
(91 %)
17 diff
(98.0 %id)
TI_57177906   .b 1650 to 2387 64 to 801       735/866
(84 %)
13 diff
(98.5 %id)
BX325469   .b 1651 to 2388 737 to 1       737/933
(78 %)
22 diff
(97.7 %id)
BQ057051 lymph, lymphoma, cell line .b 1653 to 2476 1 to 834       834/912
(91 %)
22 diff
(97.6 %id)
BI766124 pooled lung and spleen .b 1654 to 2380 1 to 727       725/727
(99 %)
8 diff
(98.9 %id)
CR994938 T-Lymphocytes .b 1661 to 2271 1 to 611       611/614
(99 %)
2 diff
(99.7 %id)
BI490316 pooled brain, lung, testis .b 1668 to 2380 714 to 1       714/715
(99 %)
9 diff
(98.8 %id)
BE792832 lung, small cell carcinoma .b 1691 to 2414 1 to 722       722/723
(99 %)
8 diff
(98.9 %id)
BQ671006 epidermoid carcinoma, cell line, salivary gland .b 1717 to 2497 1 to 784       784/915
(85 %)
19 diff
(98.0 %id)
BX349483 Neuroblastoma Cot 25-normalized .b 1733 to 2388 659 to 1       659/850
(77 %)
12 diff
(98.6 %id)
BX328442 Neuroblastoma Cot 25-normalized .b 1734 to 2388 658 to 1       658/752
(87 %)
18 diff
(97.7 %id)
BI861036 breast, mammary adenocarcinoma, cell line .b 1750 to 2378 1 to 630       630/630
(100 %)
4 diff
(99.4 %id)
TI_57193748   .b 1750 to 2388 51 to 690       640/723
(88 %)
5 diff
(99.4 %id)
BI438602 Pancreas, Purified pancreatic islet .b 1770 to 2388 620 to 2       619/620
(99 %)
0 diff
(100 %id)
CD633509   .b 1789 to 2299 742 to 234       509/528
(96 %)
2 diff
(99.7 %id)
AI829108 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 1810 to 2354 545 to 1       545/545
(100 %)
2 diff
(99.7 %id)
BX328525 Neuroblastoma Cot 25-normalized .b 1826 to 2388 563 to 1       563/851
(66 %)
7 diff
(99.2 %id)
AI871004 anaplastic oligodendroglioma, brain .b 1864 to 2354 491 to 1       491/491
(100 %)
0 diff
(100 %id)
AI146781 heart .b 1873 to 2354 483 to 1       483/483
(100 %)
2 diff
(99.6 %id)
AW024645 Kidney .b 1873 to 2354 483 to 1       483/483
(100 %)
1 diff
(99.8 %id)
BX328538 Neuroblastoma Cot 25-normalized .b 1879 to 2388 510 to 1       510/716
(71 %)
16 diff
(97.8 %id)
AI307140 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1888 to 2370 483 to 1       483/483
(100 %)
1 diff
(99.8 %id)
AA744814 germinal center B cell .b 1910 to 2354 445 to 1       445/445
(100 %)
0 diff
(100 %id)
N49869 multiple sclerosis lesions .b 1915 to 2354 443 to 1       443/443
(100 %)
7 diff
(98.5 %id)
AA742401 germinal center B cell .b 1919 to 2354 434 to 1       434/435
(99 %)
5 diff
(98.9 %id)
AW515298 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 1920 to 2203 284 to 1       284/284
(100 %)
0 diff
(100 %id)
AI433094 lymph node, lymphoma, follicular mixed small and largecell .b 1922 to 2203 282 to 1       282/282
(100 %)
1 diff
(99.7 %id)
AI524086 B-cell, chronic lymphotic leukemia .b 1923 to 2354 432 to 1       432/432
(100 %)
1 diff
(99.8 %id)
AI992156 thymus, pooled .b 1924 to 2354 431 to 1       431/431
(100 %)
9 diff
(98.0 %id)
AA993481   .b 1937 to 2354 417 to 1       417/417
(100 %)
4 diff
(99.1 %id)
AW148942 Kidney, renal cell tumor .b 1951 to 2203 253 to 1       253/253
(100 %)
6 diff
(97.7 %id)
AW976563   .b 1958 to 2388 437 to 7     Submitted on the opposite strand 431/496
(86 %)
9 diff
(98.2 %id)
BX371196   .b 1958 to 2388 431 to 1       431/514
(83 %)
23 diff
(95.6 %id)
DB543503 hippocampus .b 1958 to 2644 1 to 685     Submitted on the opposite strand 683/686
(99 %)
20 diff
(97.1 %id)
CA424576 cell lines, Chondrosarcoma .b 1958 to 2644 707 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 689/690
(99 %)
9 diff
(98.7 %id)
DB575043 hypothalamus .b 1959 to 2647 31 to 718   tiling clone, Submitted on the opposite strand 690/725
(95 %)
17 diff
(97.7 %id)
R70947 placenta .b 1964 to 2273 314 to 1       314/348
(90 %)
17 diff
(95.2 %id)
BF434004 fibrotheoma, ovary .b 1969 to 2354 386 to 1       386/415
(93 %)
16 diff
(96.2 %id)
AI699716 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 1981 to 2203 227 to 1       227/227
(100 %)
11 diff
(95.2 %id)
AI378064 B-cell, chronic lymphotic leukemia .b 1982 to 2354 373 to 1       373/373
(100 %)
2 diff
(99.5 %id)
AA417653 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1983 to 2342 1 to 360   fully sequenced,   360/360
(100 %)
6 diff
(98.4 %id)
BX115581 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1984 to 2386 1 to 403       403/403
(100 %)
1 diff
(99.8 %id)
AW778936 colon, moderately-differentiated adenocarcinoma .b 1990 to 2388 400 to 2       399/400
(99 %)
3 diff
(99.3 %id)
BU584915 uterus .b 2009 to 2520 512 to 1   tiling clone,   512/512
(100 %)
0 diff
(100 %id)
BG697507 skin .b 2017 to 2385 1 to 365       365/365
(100 %)
9 diff
(97.6 %id)
AA999733 breast .b 2019 to 2354 336 to 1       336/336
(100 %)
3 diff
(99.2 %id)
AA741332 2 pooled tumors (clear cell type), Kidney .b 2021 to 2354 334 to 1       334/334
(100 %)
1 diff
(99.8 %id)
AA972528 adenocarcinoma, colon .b 2026 to 2354 328 to 1       328/328
(100 %)
2 diff
(99.4 %id)
AI339683 adenocarcinoma, colon .b 2026 to 2354 329 to 1       329/329
(100 %)
0 diff
(100 %id)
BI909185 leukocyte .b 2027 to 2380 1 to 354       354/354
(100 %)
1 diff
(99.8 %id)
TI_57237399   .b 2028 to 2388 70 to 430       361/949
(38 %)
8 diff
(99.2 %id)
CA416594 Chondrosarcoma Cell line .b 2059 to 2644 599 to 14   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 586/586
(100 %)
4 diff
(99.4 %id)
AA808484 germinal center B cell .b 2064 to 2354 291 to 1       291/291
(100 %)
0 diff
(100 %id)
BE677588 dorsal root ganglia .b 2068 to 2379 312 to 1       312/312
(100 %)
2 diff
(99.4 %id)
TI_158435594   .b 2068 to 2388 377 to 57       321/734
(43 %)
1 diff
(99.9 %id)
AA485381 ovarian tumor, ovary .b 2069 to 2354 286 to 1       286/286
(100 %)
0 diff
(100 %id)
AA425383   .b 2078 to 2354 277 to 1       277/391
(70 %)
0 diff
(100 %id)
AI493404 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2080 to 2354 275 to 1       275/275
(100 %)
0 diff
(100 %id)
BM983038 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 2083 to 2644 581 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 563/564
(99 %)
2 diff
(99.7 %id)
AI589949 adenocarcinoma, Pancreas .b 2095 to 2201 108 to 1       108/108
(100 %)
4 diff
(96.3 %id)
AW473244 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 2099 to 2203 105 to 1       105/105
(100 %)
0 diff
(100 %id)
AI205079 schizophrenic brain S-11 frontal lobe .b 2132 to 2438 7 to 313     Submitted on the opposite strand 307/313
(98 %)
0 diff
(100 %id)
BI252853 hepatocellular carcinoma, cell line, Liver .b 2137 to 2581 475 to 13       463/486
(95 %)
12 diff
(97.6 %id)
AW197172 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .b 2139 to 2203 65 to 1       65/66
(98 %)
3 diff
(95.5 %id)
R58832   .b 2144 to 2349 206 to 1       206/206
(100 %)
0 diff
(100 %id)
BQ328202 leiomios .b 2158 to 2345 188 to 1       188/188
(100 %)
1 diff
(99.5 %id)
EC528802 Prostate .b 2169 to 2261 1 to 92       92/92
(100 %)
2 diff
(97.9 %id)
CB306387 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 2205 to 2644 459 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 441/441
(100 %)
6 diff
(98.7 %id)
AA419610 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2269 to 2354 86 to 1   fully sequenced,   86/86
(100 %)
0 diff
(100 %id)
BU585029   .b 2390 to 2457 1 to 68     Submitted on the opposite strand 68/68
(100 %)
0 diff
(100 %id)
H73491 liver and spleen .b 2409 to 2644 233 to 1       233/244
(95 %)
7 diff
(97.2 %id)
BM972642 lung .b 2440 to 2644 223 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 205/216
(94 %)
1 diff
(99.6 %id)
BU584576 colon .b 2561 to 2644 1 to 84       84/84
(100 %)
1 diff
(98.9 %id)
BI916349 brain .c 1 to 578 1 to 578   tiling clone,   578/578
(100 %)
0 diff
(100 %id)
TI_57239881   .c 1 to 578 39 to 616       578/616
(93 %)
6 diff
(99.1 %id)
BQ072772 leukocyte .c 14 to 740 15 to 745       731/1075
(68 %)
24 diff
(97.8 %id)
CR975340 T-Lymphocytes .c 22 to 649 1 to 628       628/628
(100 %)
0 diff
(100 %id)
TI_57235963   .c 122 to 1001 24 to 909       886/917
(96 %)
21 diff
(97.8 %id)
BI910408 leukocyte .c 139 to 1001 1 to 868       868/876
(99 %)
16 diff
(98.2 %id)
BF316446 brain, neuroblastoma .c 152 to 740 1 to 586       586/593
(98 %)
7 diff
(98.9 %id)
BI195906 brain, neuroblastoma .c 154 to 1001 1 to 846       846/950
(89 %)
30 diff
(96.9 %id)
TI_57231744   .c 157 to 841 30 to 707       678/707
(95 %)
10 diff
(98.6 %id)
BI521299 pooled pancreas and spleen .c 159 to 649 1 to 490       490/493
(99 %)
3 diff
(99.4 %id)
BQ073044 leukocyte .c 159 to 1062 1 to 908   tiling clone,   857/1050
(81 %)
18 diff
(98.3 %id)
BI823304 pooled brain, lung, testis .c 161 to 987 1 to 834       834/834
(100 %)
21 diff
(97.5 %id)
TI_57202813   .c 161 to 987 33 to 866       834/866
(96 %)
25 diff
(97.2 %id)
BX349514 Neuroblastoma Cot 25-normalized .c 169 to 936 1 to 769   tiling clone,   769/807
(95 %)
33 diff
(96.0 %id)
BX391404   .c 173 to 1102 1 to 929       929/929
(100 %)
6 diff
(99.4 %id)
BX400031   .c 173 to 1065 1 to 893       891/893
(99 %)
24 diff
(97.4 %id)
BM921861 pooled brain, lung, testis .c 223 to 1001 13 to 793       781/1050
(74 %)
12 diff
(98.9 %id)
BM926192 brain .c 277 to 1001 1 to 728   tiling clone,   728/1015
(71 %)
4 diff
(99.7 %id)
BX348138   .c 864 to 1540 1 to 680   tiling clone,   678/680
(99 %)
30 diff
(95.6 %id)
BI521845 pooled pancreas and spleen .c 1474 to 2276 802 to 1   tiling clone,   802/802
(100 %)
11 diff
(98.7 %id)
CR618050 B cells (Ramos cell line) Cot 25-normalized .d 1 to 2133 1 to 2133 exact tiling clone,   2133/2133
(100 %)
0 diff
(100 %id)
BX328276   .d 818 to 1679 9 to 869       861/869
(99 %)
11 diff
(98.8 %id)
BX326971   .d 819 to 1562 1 to 748       748/761
(98 %)
7 diff
(99.1 %id)
BG720648 testis .e 1 to 791 1 to 796   tiling clone,   796/796
(100 %)
10 diff
(98.8 %id)
BC094734 testis .e 6 to 2377 1 to 2372 exact tiling clone, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 2372/2372
(100 %)
1 diff
(100.0 %id)
BF758138 colon .e 334 to 512 195 to 17     Submitted on the opposite strand 179/210
(85 %)
0 diff
(100 %id)
BX394324 Neuroblastoma Cot 25-normalized .f 1 to 934 1 to 928   tiling clone,   928/928
(100 %)
11 diff
(98.9 %id)
BX368604 Neuroblastoma Cot 25-normalized .f 437 to 1203 1 to 765   tiling clone,   765/884
(86 %)
7 diff
(99.3 %id)
N43932 multiple sclerosis lesions .f 1081 to 1284 1 to 202   tiling clone,   202/202
(100 %)
3 diff
(98.6 %id)
N43924 multiple sclerosis lesions .f 1082 to 1373 1 to 298   tiling clone,   298/299
(99 %)
11 diff
(96.4 %id)
AA282114 germinal center B cell .f 1798 to 2112 1 to 314   tiling clone,   314/314
(100 %)
1 diff
(99.7 %id)
CX763298 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .f 1887 to 2613 1 to 716   tiling clone, Submitted on the opposite strand 716/758
(94 %)
21 diff
(97.3 %id)
BU584755 adrenal tumor .f 2867 to 3454 591 to 2   tiling clone,   590/595
(99 %)
2 diff
(99.7 %id)
TI_154126467   .f 2876 to 3650 872 to 99   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 774/950
(81 %)
29 diff
(97.0 %id)
N34851 multiple sclerosis lesions .f 2877 to 3360 479 to 1       479/479
(100 %)
10 diff
(98.0 %id)
N34859 multiple sclerosis lesions .f 2877 to 3360 483 to 1   tiling clone,   483/483
(100 %)
8 diff
(98.4 %id)
TI_149314913   .f 2883 to 3650 851 to 86   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 766/997
(76 %)
29 diff
(97.1 %id)
AA767215 germinal center B cell .f 2885 to 3360 473 to 1       473/474
(99 %)
7 diff
(98.6 %id)
TI_149298270   .f 2885 to 3650 852 to 87   tiling clone, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 766/931
(82 %)
20 diff
(97.9 %id)
BF738476 bladder_tumor .f 2893 to 3355 9 to 471       462/471
(98 %)
11 diff
(97.7 %id)
AA282115 germinal center B cell .f 3065 to 3360 295 to 1       295/295
(100 %)
3 diff
(99.0 %id)
BI522730 brain .g 1 to 909 1 to 920   tiling clone,   920/934
(98 %)
22 diff
(97.7 %id)
TI_44185610   .g 1 to 909 33 to 952       920/966
(95 %)
28 diff
(97.2 %id)
BI522901 brain .g 1413 to 2080 664 to 1   tiling clone,   664/664
(100 %)
5 diff
(99.3 %id)
TI_44185611   .g 1413 to 2088 715 to 44   tiling clone,   672/715
(93 %)
5 diff
(99.4 %id)
AW118614 pooled .g 1495 to 2054 560 to 1   tiling clone,   560/560
(100 %)
1 diff
(99.9 %id)
AA503359 colon .g 1540 to 2054 510 to 1       510/510
(100 %)
12 diff
(97.7 %id)
AA523726 colon .g 1575 to 2054 480 to 1       480/580
(82 %)
77 diff
(86.8 %id)
AI494562 B-cell, chronic lymphotic leukemia .g 1660 to 2054 395 to 1       395/395
(100 %)
2 diff
(99.5 %id)
AA766238 germinal center B cell .g 1691 to 2019 329 to 1       329/329
(100 %)
1 diff
(99.7 %id)
AW002138 thymus, pooled .g 1727 to 2054 328 to 1       328/328
(100 %)
8 diff
(97.6 %id)
AW002165 thymus, pooled .g 1759 to 2054 301 to 1       301/302
(99 %)
10 diff
(96.7 %id)
AI749381 aorta .g 1770 to 2054 285 to 1   tiling clone,   285/285
(100 %)
1 diff
(99.7 %id)
AA872526 germinal center B cell .g 1808 to 2054 247 to 1       247/254
(97 %)
0 diff
(100 %id)
AW001316 colon, colonic mucosa from 3 patients with Crohn'sdisease .g 1808 to 2021 214 to 1       214/220
(97 %)
3 diff
(98.7 %id)
BI522549 brain .h 1 to 772 1 to 763   tiling clone,   763/763
(100 %)
10 diff
(98.7 %id)
TI_44184815   .h 1 to 772 28 to 790       763/790
(96 %)
13 diff
(98.4 %id)
BI523493 brain .h 1258 to 1817 884 to 301       579/885
(65 %)
45 diff
(95.0 %id)
TI_44184816   .h 1258 to 1817 884 to 301   tiling clone,   579/885
(65 %)
45 diff
(95.0 %id)
CD580357 brain .i 1 to 714 1 to 714   tiling clone,   714/820
(87 %)
4 diff
(99.6 %id)
TI_43961456   .i 490 to 1227 62 to 796       735/796
(92 %)
7 diff
(99.2 %id)
BI489670 pooled brain, lung, testis .i 496 to 1227 1 to 729   tiling clone,   729/729
(100 %)
3 diff
(99.6 %id)
BI490492 pooled brain, lung, testis .i 1824 to 2421 597 to 1   tiling clone,   597/599
(99 %)
2 diff
(99.7 %id)
TI_43961457   .i 1824 to 2429 648 to 44   tiling clone,   605/650
(93 %)
2 diff
(99.7 %id)
AY450395   .j 1 to 1857 1 to 1856 A92T Q177R tiling clone,   1856/1856
(100 %)
6 diff
(99.7 %id)
BM922983 leukocyte .k 1 to 877 6 to 887   tiling clone,   882/1060
(83 %)
14 diff
(98.7 %id)
TI_57179934   .k 7 to 700 24 to 714       691/714
(96 %)
18 diff
(97.5 %id)
BI770430 pooled lung and spleen .k 10 to 700 1 to 688       688/688
(100 %)
17 diff
(97.6 %id)
TI_43960811   .k 17 to 700 82 to 762       681/762
(89 %)
10 diff
(98.7 %id)
BI770646 pooled lung and spleen .k 165 to 897 1 to 736   tiling clone,   736/737
(99 %)
27 diff
(96.4 %id)
TI_57183555   .k 165 to 897 32 to 767       736/768
(95 %)
30 diff
(96.1 %id)
BI770411 pooled lung and spleen .k 903 to 1749 1 to 841   tiling clone,   841/841
(100 %)
24 diff
(97.2 %id)
TI_57179914   .k 903 to 1749 27 to 867       841/867
(97 %)
28 diff
(96.8 %id)
TI_43960812   .k 1686 to 2406 762 to 41   tiling clone,   722/763
(94 %)
8 diff
(99.0 %id)
CR609920 HeLa cells Cot 25-normalized .l 1 to 2091 1 to 2091 exact tiling clone,   2091/2091
(100 %)
0 diff
(100 %id)
BX371270   .l 1 to 962 1 to 962       962/962
(100 %)
4 diff
(99.6 %id)
BX384457   .l 1 to 920 1 to 917       919/917
(100 %)
31 diff
(96.7 %id)
CR607842 Placenta Cot 25-normalized .m 1 to 2038 1 to 2038 exact tiling clone,   2038/2038
(100 %)
0 diff
(100 %id)
BX359606 Placenta Cot 25-normalized .m 1 to 957 1 to 956       956/956
(100 %)
18 diff
(98.2 %id)
BG330831 large cell carcinoma, lung .m 11 to 711 1 to 692       692/896
(77 %)
14 diff
(98.5 %id)
BX328526 Neuroblastoma Cot 25-normalized .m 18 to 1025 1 to 1004       1004/1004
(100 %)
13 diff
(98.8 %id)
BX355015 Neuroblastoma Cot 25-normalized .m 18 to 834 1 to 817       817/817
(100 %)
2 diff
(99.8 %id)
CD579891 brain .m 506 to 853 1 to 348       348/700
(49 %)
9 diff
(98.8 %id)
BX368924   .m 636 to 1300 1 to 665       667/665
(100 %)
9 diff
(98.7 %id)
BX326828 Neuroblastoma Cot 25-normalized .m 685 to 1473 1 to 791       791/798
(99 %)
20 diff
(97.5 %id)
BX347995 Placenta Cot 25-normalized .m 708 to 1363 1 to 655       655/673
(97 %)
15 diff
(97.8 %id)
DA241939 brain .n 1 to 584 2 to 584   tiling clone, capped   583/583
(100 %)
4 diff
(99.4 %id)
BX420508 brain, fetal brain .n 21 to 1043 1 to 1010   tiling clone,   1010/1032
(97 %)
17 diff
(98.4 %id)
BX449640 brain, fetal brain .n 79 to 979 892 to 1   tiling clone,   892/892
(100 %)
40 diff
(95.6 %id)
BP279442   .n 215 to 796 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
AB209419 brain .n 284 to 6268 1 to 5985 exact tiling clone,   5985/5985
(100 %)
18 diff
(99.7 %id)
BX347696   .n 333 to 906 574 to 1       574/697
(82 %)
16 diff
(97.8 %id)
H55067   .n 336 to 394 1 to 59       59/59
(100 %)
0 diff
(100 %id)
BX430134 neuroblastoma .n 336 to 852 517 to 1       517/517
(100 %)
2 diff
(99.7 %id)
BI045791 prostate_normal .n 351 to 771 426 to 7       420/463
(90 %)
5 diff
(99.0 %id)
BX325559 Neuroblastoma Cot 25-normalized .n 390 to 1097 709 to 5       705/871
(80 %)
13 diff
(98.6 %id)
BX388314   .n 395 to 1259 1 to 855       855/966
(88 %)
29 diff
(97.0 %id)
BQ687697 ductal carcinoma, cell line, Pancreas .n 411 to 1287 1 to 883   tiling clone,   883/885
(99 %)
13 diff
(98.6 %id)
BX368386   .n 412 to 985 572 to 1       572/584
(97 %)
33 diff
(94.4 %id)
BX368556   .n 445 to 1107 1 to 662       662/743
(89 %)
11 diff
(98.6 %id)
BX407279 T cells (Jurkat cell line) .n 451 to 1245 18 to 795       778/924
(84 %)
37 diff
(96.0 %id)
BX368918   .n 532 to 835 1 to 305       305/305
(100 %)
10 diff
(96.8 %id)
BX368507   .n 537 to 1155 621 to 3       619/776
(79 %)
2 diff
(99.8 %id)
BX325578   .n 542 to 1444 905 to 8       898/905
(99 %)
16 diff
(98.3 %id)
BX099191 brain .n 577 to 1180 605 to 1     Submitted on the opposite strand 605/605
(100 %)
2 diff
(99.7 %id)
EC517504 Prostate .n 583 to 679 13 to 108       96/108
(88 %)
6 diff
(94.5 %id)
EC547040 Prostate .n 583 to 679 12 to 108       97/108
(89 %)
6 diff
(94.5 %id)
EC581438 Prostate .n 583 to 680 12 to 106       95/106
(89 %)
6 diff
(94.4 %id)
BX424242 T cells (Jurkat cell line) .n 587 to 1640 1060 to 8       1053/1060
(99 %)
33 diff
(96.9 %id)
BX383123   .n 594 to 1630 1024 to 1       1024/1033
(99 %)
27 diff
(97.4 %id)
BX388249 Neuroblastoma Cot 50-normalized .n 598 to 1666 1058 to 1       1058/1067
(99 %)
48 diff
(95.6 %id)
BX342714   .n 600 to 1623 1016 to 1       1016/1026
(99 %)
34 diff
(96.7 %id)
BX430365 neuroblastoma .n 607 to 932 1 to 328       328/362
(90 %)
8 diff
(97.8 %id)
AW673542 cervix .n 630 to 838 25 to 233       209/233
(89 %)
9 diff
(96.2 %id)
BX411111 T cells (Jurkat cell line) .n 631 to 1657 1017 to 1       1017/1017
(100 %)
16 diff
(98.5 %id)
BI767461 pooled lung and spleen .n 645 to 1507 1 to 874       874/875
(99 %)
18 diff
(98.0 %id)
TI_57181171   .n 645 to 1507 67 to 940       874/941
(92 %)
24 diff
(97.5 %id)
BX424688 neuroblastoma .n 699 to 1634 958 to 23       936/1059
(88 %)
15 diff
(98.6 %id)
BX370823 Neuroblastoma Cot 10-normalized .n 714 to 1643 936 to 8   tiling clone,   929/936
(99 %)
4 diff
(99.6 %id)
BX333893 Neuroblastoma Cot 50-normalized .n 717 to 1593 921 to 48       874/921
(94 %)
9 diff
(99.1 %id)
BX341531   .n 721 to 1639 948 to 28       921/948
(97 %)
3 diff
(99.7 %id)
BG030840 breast, mammary adenocarcinoma, cell line .n 769 to 1612 1 to 837       837/899
(93 %)
24 diff
(97.4 %id)
BM792027 Ascites, stomach .n 769 to 1288 1 to 520       520/520
(100 %)
5 diff
(99.1 %id)
BX353715 Neuroblastoma Cot 25-normalized .n 772 to 1631 860 to 1       860/860
(100 %)
28 diff
(96.8 %id)
BX428236 neuroblastoma .n 774 to 1635 867 to 16       852/929
(91 %)
12 diff
(98.8 %id)
BX340521   .n 775 to 1647 868 to 1       868/868
(100 %)
11 diff
(98.8 %id)
BQ433008 large cell carcinoma, lung .n 805 to 1681 36 to 912       877/912
(96 %)
13 diff
(98.6 %id)
H14292 brain .n 807 to 1180 378 to 2     Submitted on the opposite strand 377/393
(95 %)
7 diff
(98.3 %id)
BF918628 nervous_tumor .n 873 to 1056 13 to 198       186/209
(88 %)
9 diff
(95.7 %id)
R87210 brain .n 986 to 1041 56 to 1     Submitted on the opposite strand 56/61
(91 %)
1 diff
(98.4 %id)
AW731696 cervix .n 1350 to 1680 331 to 1       331/331
(100 %)
0 diff
(100 %id)
AJ346078 pectoral muscle (after mastectomy) .n 1359 to 1683 16 to 340       325/349
(93 %)
1 diff
(99.8 %id)
CD580360 brain .n 3197 to 3663 1 to 470       470/895
(52 %)
14 diff
(98.5 %id)
BM149082 leukopheresis .n 3319 to 3930 1 to 611       611/611
(100 %)
7 diff
(98.9 %id)
CN301619 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 3339 to 3611 1 to 273       273/281
(97 %)
3 diff
(99.0 %id)
BX336413 Placenta Cot 25-normalized .n 3341 to 3611 1 to 270       270/270
(100 %)
3 diff
(98.9 %id)
BX456855 thymus .n 3370 to 4130 1 to 756   tiling clone,   756/756
(100 %)
13 diff
(98.3 %id)
BF757868 colon .n 4118 to 4253 1 to 132       132/137
(96 %)
9 diff
(93.5 %id)
BU584651 brain .n 4387 to 4848 1 to 461   tiling clone,   461/461
(100 %)
3 diff
(99.4 %id)
BF858374 prostate_tumor .n 4555 to 4768 1 to 213       213/218
(97 %)
10 diff
(95.5 %id)
EC493861 Prostate .n 4995 to 5089 1 to 95       95/95
(100 %)
5 diff
(94.8 %id)
EC463963 Prostate .n 4997 to 5089 1 to 93       93/93
(100 %)
0 diff
(100 %id)
BQ422522 large cell carcinoma, lung .n 5026 to 5729 1 to 704       704/946
(74 %)
16 diff
(98.4 %id)
BG750338 eye, normal pigmented retinal epithelium .n 5055 to 5709 1 to 655   tiling clone,   655/655
(100 %)
2 diff
(99.7 %id)
BX326785 Neuroblastoma Cot 25-normalized .n 5149 to 6047 9 to 906       898/906
(99 %)
15 diff
(98.4 %id)
BG678925 skin, squamous cell carcinoma .n 5266 to 6014 1 to 746       746/746
(100 %)
7 diff
(99.1 %id)
BM919124 pooled pancreas and spleen .n 5336 to 5877 1 to 540       540/1012
(53 %)
11 diff
(99.0 %id)
TI_151754362   .n 5372 to 6276 924 to 25   tiling clone,   900/993
(90 %)
13 diff
(98.7 %id)
CU447234 epidermis .n 5541 to 5717 200 to 24     Submitted on the opposite strand 177/217
(81 %)
1 diff
(99.6 %id)
BM819644 stomach .n 5572 to 6092 1 to 519       519/519
(100 %)
2 diff
(99.7 %id)
BM821031 stomach .n 5572 to 6092 1 to 521       521/521
(100 %)
2 diff
(99.7 %id)
BM852223 stomach .n 5572 to 6092 1 to 521       521/521
(100 %)
1 diff
(99.9 %id)
BM821925 stomach .n 5605 to 5917 1 to 313       313/313
(100 %)
1 diff
(99.7 %id)
BM821943 stomach .n 5609 to 5751 1 to 143       143/143
(100 %)
0 diff
(100 %id)
BG878396 uterus .n 5722 to 5874 164 to 316       153/164
(93 %)
1 diff
(99.4 %id)
AW512469 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .n 5957 to 6125 176 to 8       169/176
(96 %)
0 diff
(100 %id)
BX354863 Neuroblastoma Cot 25-normalized .o 1 to 858 1 to 858   tiling clone,   858/959
(89 %)
26 diff
(97.3 %id)
CR998127 T-Lymphocytes .o 37 to 616 1 to 580   tiling clone,   580/582
(99 %)
3 diff
(99.5 %id)
BX389239 Neuroblastoma Cot 25-normalized .o 588 to 1032 1 to 446       446/581
(76 %)
7 diff
(98.8 %id)
BX389240 Neuroblastoma Cot 25-normalized .o 588 to 1283 1 to 697   tiling clone,   697/697
(100 %)
33 diff
(95.3 %id)
BX389241 Neuroblastoma Cot 25-normalized .o 599 to 1295 10 to 710   tiling clone,   701/864
(81 %)
26 diff
(97.0 %id)
CR456515   .p 1 to 1146 3 to 1148 T114M tiling clone,   1148/1154
(99 %)
4 diff
(99.7 %id)
CU013403 Synthetic constructs .p 32 to 1108 18 to 1094       1077/1105
(97 %)
12 diff
(99.0 %id)
CU013115 Synthetic constructs .p 32 to 1113 18 to 1099       1082/1108
(97 %)
13 diff
(98.9 %id)
DR000935 fetal brain .q 1 to 653 1 to 656   tiling clone,   656/656
(100 %)
3 diff
(99.6 %id)
U66243   .q 10 to 1468 92 to 1550 Y261N     1459/1491
(97 %)
13 diff
(99.2 %id)
CR595847 Neuroblastoma Cot 25-normalized .q 74 to 1871 1 to 1798 exact     1798/1798
(100 %)
0 diff
(100 %id)
CR597471 T cells (Jurkat cell line) .q 74 to 1897 1 to 1824 exact     1824/1824
(100 %)
0 diff
(100 %id)
BX424243 T cells (Jurkat cell line) .q 81 to 1090 6 to 1010       1005/1081
(92 %)
40 diff
(96.3 %id)
BX462506 T cells (Jurkat cell line) .q 87 to 1092 1 to 997       997/1000
(99 %)
20 diff
(98.0 %id)
BX353716 Neuroblastoma Cot 25-normalized .q 88 to 1092 13 to 1015       1003/1057
(94 %)
23 diff
(97.9 %id)
BX411112 T cells (Jurkat cell line) .q 88 to 1063 13 to 981       969/981
(98 %)
14 diff
(98.6 %id)
BX340916   .q 114 to 1074 1 to 960       960/960
(100 %)
3 diff
(99.7 %id)
BX367423   .q 114 to 824 1 to 709       709/709
(100 %)
3 diff
(99.6 %id)
Y10487 skeletal muscle .q 114 to 1922 1 to 1808 exact     1808/1808
(100 %)
2 diff
(99.9 %id)
CR614110 neuroblastoma .q 115 to 1895 1 to 1781 exact     1781/1781
(100 %)
0 diff
(100 %id)
BX424689 neuroblastoma .q 115 to 1091 1 to 972       972/972
(100 %)
21 diff
(97.9 %id)
BX438174 neuroblastoma .q 118 to 981 1 to 866       866/866
(100 %)
11 diff
(98.8 %id)
CR600878 Neuroblastoma Cot 10-normalized .q 120 to 1889 1 to 1770 exact     1770/1770
(100 %)
0 diff
(100 %id)
BX331268 Neuroblastoma Cot 10-normalized .q 120 to 1043 1 to 922       925/922
(100 %)
10 diff
(99.0 %id)
BX370824 Neuroblastoma Cot 10-normalized .q 120 to 1006 1 to 885       885/885
(100 %)
4 diff
(99.6 %id)
CR603767 Neuroblastoma Cot 50-normalized .q 121 to 1906 1 to 1786 exact tiling clone,   1786/1786
(100 %)
0 diff
(100 %id)
BX333894 Neuroblastoma Cot 50-normalized .q 121 to 1079 1 to 954       954/954
(100 %)
9 diff
(99.1 %id)
BX388250 Neuroblastoma Cot 50-normalized .q 121 to 1161 1 to 1028       850/1028
(82 %)
38 diff
(96.4 %id)
BX401468   .q 132 to 1010 1 to 872       875/948
(92 %)
45 diff
(95.3 %id)
CR617313 B cells (Ramos cell line) Cot 25-normalized .q 148 to 1863 1 to 1716 exact     1716/1716
(100 %)
0 diff
(100 %id)
BX342715   .q 160 to 1072 15 to 924       910/927
(98 %)
30 diff
(96.8 %id)
DB503621 hypothalamus .q 163 to 638 1 to 476       476/476
(100 %)
5 diff
(99.0 %id)
BG831699 epithelioid carcinoma cell line, Pancreas .q 169 to 871 1 to 703       703/703
(100 %)
3 diff
(99.6 %id)
BC015741 Pancreas, epithelioid carcinoma .q 170 to 1923 1 to 1754 exact available from MGC, AAA   1754/1754
(100 %)
5 diff
(99.8 %id)
NM_002969.3   .q 170 to 1923 1 to 1754 exact RefSeq, AAA   1754/1754
(100 %)
1 diff
(100.0 %id)
CR601459 T cells (Jurkat cell line) Cot10-normalized .q 186 to 1884 1 to 1699 exact     1699/1699
(100 %)
0 diff
(100 %id)
BX361647   .q 186 to 1009 1 to 818       821/818
(100 %)
29 diff
(96.5 %id)
CR591936 T cells (Jurkat cell line) Cot10-normalized .q 273 to 1870 1 to 1598 exact     1598/1598
(100 %)
0 diff
(100 %id)
X79483 skeletal muscle .q 288 to 1921 1 to 1634 A7T R70L L138M M201I R202A ... AAA   1634/1634
(100 %)
31 diff
(98.2 %id)
BX389136   .q 291 to 982 692 to 1       692/709
(97 %)
13 diff
(98.2 %id)
BX367519   .q 300 to 1159 856 to 1       856/856
(100 %)
15 diff
(98.3 %id)
TI_1948085777   .q 317 to 896 125 to 709       546/1392
(39 %)
36 diff
(97.5 %id)
TI_1948085928   .q 317 to 942 119 to 747       629/1446
(43 %)
31 diff
(97.9 %id)
TI_1948086090   .q 317 to 896 126 to 707   fully sequenced,   582/707
(82 %)
10 diff
(98.6 %id)
CV029047 mixed .q 321 to 961 1 to 641       641/641
(100 %)
2 diff
(99.7 %id)
DA300171 hippocampus .q 346 to 929 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
CN409631 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .q 388 to 1096 1 to 709       709/718
(98 %)
7 diff
(99.1 %id)
BM926932 brain .q 419 to 1205 15 to 803       789/1022
(77 %)
18 diff
(98.3 %id)
BX362689   .q 441 to 1289 1 to 844       844/844
(100 %)
10 diff
(98.9 %id)
CA487521   .q 442 to 1270 1 to 834       834/1000
(83 %)
21 diff
(97.9 %id)
DA294973 hippocampus .q 446 to 998 2 to 554   capped   553/553
(100 %)
2 diff
(99.7 %id)
DA304422 hippocampus .q 446 to 1019 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
BE904841 epithelioid carcinoma, Pancreas .q 446 to 1153 1 to 711       711/714
(99 %)
15 diff
(97.9 %id)
BX367517 Neuroblastoma Cot 50-normalized .q 447 to 1305 853 to 1       853/970
(87 %)
31 diff
(96.9 %id)
BX407324 neuroblastoma .q 451 to 1295 836 to 1       836/985
(84 %)
44 diff
(95.6 %id)
BI160607 epithelioid carcinoma cell line, Pancreas .q 453 to 1221 1 to 775       775/776
(99 %)
14 diff
(98.2 %id)
BE906571 epithelioid carcinoma, Pancreas .q 477 to 1256 1 to 768       770/787
(97 %)
21 diff
(97.4 %id)
TI_57216011   .q 484 to 1223 22 to 760       739/760
(97 %)
8 diff
(99.0 %id)
BI755093 brain .q 491 to 1223 1 to 732       732/732
(100 %)
3 diff
(99.6 %id)
CB123561 Liver .q 498 to 1091 1 to 593       593/593
(100 %)
5 diff
(99.2 %id)
BI757549 brain .q 524 to 1347 1 to 825       825/913
(90 %)
7 diff
(99.3 %id)
TI_57220423   .q 524 to 1347 24 to 848       825/936
(88 %)
13 diff
(98.7 %id)
TI_1948086091   .q 866 to 1430 685 to 114   fully sequenced,   572/685
(83 %)
17 diff
(97.6 %id)
BX420507 brain, fetal brain .q 1089 to 1874 794 to 6       789/1019
(77 %)
8 diff
(99.3 %id)
BX411696 neuroblastoma .q 1091 to 1922 835 to 1       835/925
(90 %)
22 diff
(97.7 %id)
TI_151809054   .q 1104 to 1919 73 to 881   fully sequenced,   809/809
(100 %)
17 diff
(97.9 %id)
BX367422   .q 1121 to 1885 767 to 5       763/769
(99 %)
2 diff
(99.8 %id)
BX363535   .q 1139 to 1889 751 to 1       751/1013
(74 %)
6 diff
(99.5 %id)
TI_151729669   .q 1140 to 1920 865 to 85   fully sequenced, AAA   781/781
(100 %)
1 diff
(99.9 %id)
BP317230 pericardium .q 1151 to 1733 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BX336139 Placenta Cot 25-normalized .q 1171 to 1895 732 to 1       732/732
(100 %)
61 diff
(91.7 %id)
BX438173 neuroblastoma .q 1179 to 1880 700 to 1       700/707
(99 %)
37 diff
(94.8 %id)
BI916114 brain .q 1182 to 1921 1 to 741       741/834
(88 %)
3 diff
(99.7 %id)
TI_57239013   .q 1182 to 1921 30 to 770   AAA   741/849
(87 %)
9 diff
(99.0 %id)
AI935726 Kidney .q 1203 to 1918 715 to 1       715/715
(100 %)
10 diff
(98.7 %id)
BI084393 epidermoid carcinoma, cell line, salivary gland .q 1222 to 1851 1 to 631   fully sequenced,   631/631
(100 %)
12 diff
(98.1 %id)
CK299064 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .q 1251 to 1920 688 to 19   AAA   670/670
(100 %)
0 diff
(100 %id)
CA431247 cell lines, Enchondroma .q 1262 to 1923 680 to 19   AAA   662/662
(100 %)
0 diff
(100 %id)
BX330115 Placenta Cot 25-normalized .q 1283 to 1921 644 to 1       644/768
(83 %)
26 diff
(96.7 %id)
BM718093 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .q 1303 to 1609 1 to 307   fully sequenced,   307/307
(100 %)
0 diff
(100 %id)
BI085009 epidermoid carcinoma, cell line, salivary gland .q 1309 to 1756 450 to 1   fully sequenced,   450/450
(100 %)
3 diff
(99.4 %id)
BQ941412 epidermoid carcinoma, cell line, lung .q 1318 to 1924 1 to 607   tiling clone,   607/608
(99 %)
1 diff
(99.9 %id)
BX455977 T cells (Jurkat cell line) .q 1340 to 1888 556 to 8       549/692
(79 %)
0 diff
(100 %id)
BX401467   .q 1365 to 1882 520 to 1       520/520
(100 %)
17 diff
(96.8 %id)
EC518178 Prostate .q 1393 to 1503 1 to 111       111/111
(100 %)
0 diff
(100 %id)
N94360 senescent fibroblast .q 1441 to 1924 497 to 12   AAA   486/490
(99 %)
10 diff
(98.0 %id)
DB548195 hippocampus .q 1449 to 1920 1 to 472     Submitted on the opposite strand 472/472
(100 %)
0 diff
(100 %id)
AI936909 anaplastic oligodendroglioma, brain .q 1461 to 1920 468 to 9       460/468
(98 %)
0 diff
(100 %id)
CA415888 Chondrosarcoma Cell line .q 1475 to 1923 467 to 19   AAA   449/449
(100 %)
0 diff
(100 %id)
AI862304 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .q 1482 to 1920 440 to 2       439/440
(99 %)
0 diff
(100 %id)
DB531327 hippocampus .q 1492 to 1922 1 to 430     Submitted on the opposite strand 430/430
(100 %)
4 diff
(99.1 %id)
EC565009 Prostate .q 1509 to 1606 1 to 98       98/98
(100 %)
0 diff
(100 %id)
AJ346582 pectoral muscle (after mastectomy) .q 1533 to 1915 8 to 390       383/390
(98 %)
6 diff
(98.5 %id)
AJ572558 pectoral muscle (after mastectomy) .q 1533 to 1905 14 to 382       369/382
(96 %)
6 diff
(98.5 %id)
F24963 pectoral muscle (after mastectomy) .q 1540 to 1924 1 to 385       385/385
(100 %)
2 diff
(99.5 %id)
BX355236 Neuroblastoma Cot 50-normalized .q 1541 to 1918 1 to 378       378/378
(100 %)
0 diff
(100 %id)
AI928571 anaplastic oligodendroglioma, brain .q 1547 to 1920 383 to 9       375/383
(97 %)
0 diff
(100 %id)
F33806 pectoral muscle (after mastectomy) .q 1548 to 1758 1 to 211       211/211
(100 %)
1 diff
(99.6 %id)
F34120 pectoral muscle (after mastectomy) .q 1553 to 1922 1 to 370       370/379
(97 %)
4 diff
(99.0 %id)
F35709 pectoral muscle (after mastectomy) .q 1557 to 1819 1 to 260       260/260
(100 %)
3 diff
(98.9 %id)
F32857 pectoral muscle (after mastectomy) .q 1560 to 1851 1 to 292       292/292
(100 %)
13 diff
(95.6 %id)
AJ572991 pectoral muscle (after mastectomy) .q 1570 to 1922 13 to 364   AAA   352/364
(96 %)
6 diff
(98.4 %id)
BM680543 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .q 1579 to 1922 363 to 19   fully sequenced, AAA   345/345
(100 %)
2 diff
(99.5 %id)
AW451717   .q 1608 to 1920 330 to 18   AAA   313/318
(98 %)
0 diff
(100 %id)
AJ346845 pectoral muscle (after mastectomy) .q 1618 to 1923 12 to 317       306/318
(96 %)
2 diff
(99.4 %id)
AW295265   .q 1666 to 1922 274 to 18   AAA   257/267
(96 %)
0 diff
(100 %id)
AI651009 pooled germ cell tumors .q 1699 to 1922 226 to 3       224/226
(99 %)
0 diff
(100 %id)
BE464142 pooled germ cell tumors .q 1699 to 1922 226 to 3       224/226
(99 %)
0 diff
(100 %id)
BE541005 cervix .q 1793 to 1919 1 to 125       125/125
(100 %)
2 diff
(98.4 %id)
AI989576 pooled germ cell tumors .q 1868 to 1923 73 to 18   AAA   56/56
(100 %)
0 diff
(100 %id)
BE504625 pooled germ cell tumors .q 1868 to 1923 73 to 18   AAA   56/56
(100 %)
0 diff
(100 %id)
BX640648 human colon endothel primary cell culture .r 1 to 1459 1 to 1459 exact tiling clone, available from DKFZ, AAA   1459/1459
(100 %)
3 diff
(99.8 %id)
AA215546 germinal center B cell .s 1 to 216 1 to 216   tiling clone,   216/217
(99 %)
1 diff
(99.6 %id)
AA280231 germinal center B cell .s 1 to 270 1 to 269   tiling clone,   269/269
(100 %)
5 diff
(98.2 %id)
AA215469 germinal center B cell .s 672 to 1131 468 to 1   tiling clone,   468/479
(97 %)
22 diff
(95.5 %id)
AA281468 germinal center B cell .s 957 to 1131 174 to 1       174/174
(100 %)
1 diff
(99.5 %id)
BI523867 pooled lung and spleen .t 1 to 485 1 to 486   tiling clone,   486/489
(99 %)
5 diff
(99.0 %id)
TI_44158863   .t 1 to 485 79 to 564       486/567
(85 %)
11 diff
(98.1 %id)
BX396651 Placenta Cot 25-normalized .t 581 to 1510 1 to 943   tiling clone,   887/943
(94 %)
37 diff
(96.1 %id)
BX343767 Placenta Cot 25-normalized .t 581 to 1573 1 to 976   tiling clone,   976/1008
(96 %)
20 diff
(98.1 %id)
BI524478 pooled lung and spleen .t 1569 to 2362 806 to 1   tiling clone,   801/811
(98 %)
25 diff
(97.0 %id)
TI_44158864   .t 1569 to 2370 857 to 44   tiling clone,   809/862
(93 %)
25 diff
(97.1 %id)
BC032423 Blood, adult leukocytes .u 1 to 1786 1 to 1786 K260E tiling clone, available from MGC,   1786/1786
(100 %)
5 diff
(99.8 %id)
BI912484 leukocyte .u 3 to 810 1 to 805   available from MGC,   805/820
(98 %)
15 diff
(98.2 %id)
TI_57247420   .u 3 to 810 29 to 833       805/848
(94 %)
18 diff
(97.9 %id)
BX328540 Neuroblastoma Cot 25-normalized .va 1 to 1025 1 to 959   tiling clone,   777/959
(81 %)
39 diff
(96.0 %id)
BX406109 fetal liver, Liver .va 105 to 875 1 to 769   tiling clone,   769/827
(92 %)
22 diff
(97.4 %id)
BM549744 leukocyte .va 109 to 736 15 to 652       638/1145
(55 %)
17 diff
(98.6 %id)
BQ049093 lymph, lymphoma, cell line .va 115 to 1012 1 to 906   tiling clone,   906/1009
(89 %)
12 diff
(98.9 %id)
BM546860 ovary (pool of 3) .va 126 to 875 20 to 774   tiling clone,   755/1134
(66 %)
17 diff
(98.6 %id)
BU838572 dorsal root ganglia .va 431 to 1240 1 to 810 A216X F217L E218* tiling clone,   810/968
(83 %)
12 diff
(98.8 %id)
CF131331 Chondrosarcoma Lung Metastasis cell lines, lung .vb 1 to 722 1 to 722   tiling clone,   722/722
(100 %)
1 diff
(99.9 %id)
TI_159676411   .vb 1 to 681 49 to 729 A247X     778/1030
(75 %)
14 diff
(98.7 %id)
CR604558 fetal brain .vc 1 to 2021 1 to 2021 exact tiling clone,   2021/2021
(100 %)
0 diff
(100 %id)
BX453150 brain, fetal brain .vc 1 to 844 1 to 835 W194*     835/845
(98 %)
20 diff
(97.7 %id)
BX453151 brain, fetal brain .vc 1 to 499 1 to 499       499/504
(99 %)
26 diff
(94.9 %id)
BX460607 brain, fetal brain .vc 1 to 943 1 to 943 C216R P221L D227N     943/943
(100 %)
8 diff
(99.2 %id)
BX353583 Neuroblastoma Cot 25-normalized .vd 1 to 988 1 to 985   tiling clone,   985/985
(100 %)
8 diff
(99.2 %id)
BX328443 Neuroblastoma Cot 25-normalized .vd 3 to 927 1 to 926   tiling clone,   926/926
(100 %)
3 diff
(99.7 %id)
AL512711 amygdala .vd 902 to 2122 1 to 1221   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 1221/1221
(100 %)
0 diff
(100 %id)
BM313546 Pancreas, Purified pancreatic islet .vd 1398 to 1891 1 to 494       494/494
(100 %)
2 diff
(99.6 %id)
BM313388 Pancreas, Purified pancreatic islet .vd 1651 to 2123 473 to 1       473/473
(100 %)
2 diff
(99.6 %id)
AI870422 anaplastic oligodendroglioma, brain .vd 1668 to 2123 457 to 1   tiling clone,   457/457
(100 %)
2 diff
(99.6 %id)
AW511499 pooled germ cell tumors .vd 1682 to 2123 442 to 1       442/442
(100 %)
1 diff
(99.8 %id)
BC125082 PCR rescued clones .ve 1 to 1634 1 to 1634 exact tiling clone,   1634/1634
(100 %)
1 diff
(100.0 %id)
CR983170 T-Lymphocytes .ve 660 to 1301 1 to 642       642/642
(100 %)
0 diff
(100 %id)
BX391339 Placenta Cot 25-normalized .ve 759 to 1597 836 to 1 L20X D21X     836/836
(100 %)
16 diff
(98.1 %id)
BI261751 lymph, lymphoma, cell line .ve 923 to 1633 1 to 711 exact     711/711
(100 %)
1 diff
(99.9 %id)
BG703122 brain, hippocampus .vf 1 to 569 1 to 561   tiling clone,   561/596
(94 %)
21 diff
(96.5 %id)
BP351115   .vf 49 to 631 1 to 583   tiling clone,   583/583
(100 %)
4 diff
(99.4 %id)
DB464900 hippocampus .vf 56 to 470 1 to 415   tiling clone,   415/415
(100 %)
2 diff
(99.6 %id)
AK294422 amygdala .vf 58 to 1026 1 to 969 C185R P190L D196N     969/969
(100 %)
7 diff
(99.3 %id)
DC317072 amygdala .vf 58 to 573 1 to 516       516/516
(100 %)
2 diff
(99.7 %id)
DN994799 brain, whole brain .vf 65 to 608 1 to 544       544/544
(100 %)
5 diff
(99.1 %id)
CR620424 adult brain .vf 130 to 2230 1 to 2101 exact tiling clone,   2101/2101
(100 %)
0 diff
(100 %id)
BX445431 adult brain, brain .vf 130 to 997 1 to 865 E116D Q117S R118G V119*     865/930
(93 %)
20 diff
(97.9 %id)
BX463587 adult brain, brain .vf 130 to 1137 1 to 1000 E56G E116D Q117S R118G V119*     1000/1006
(99 %)
21 diff
(98.0 %id)
AK307724 uterus .vf 421 to 1841 1 to 1421       1421/1421
(100 %)
0 diff
(100 %id)
DC421711 uterus .vf 421 to 969 1 to 549       549/549
(100 %)
0 diff
(100 %id)
BF345802 anaplastic oligodendroglioma with 1p/19qloss, brain .vf 508 to 1215 1 to 705       705/712
(99 %)
15 diff
(97.9 %id)
BQ709965 Spleen .vf 596 to 1473 1 to 891       891/938
(94 %)
37 diff
(96.1 %id)
BX407220 brain, fetal brain .vf 831 to 1752 1 to 911       911/1006
(90 %)
31 diff
(97.0 %id)
BX451326 adult brain, brain .vf 944 to 1679 1 to 740       740/858
(86 %)
36 diff
(95.9 %id)
BX410280 adult brain, brain .vf 947 to 1866 1 to 921       921/923
(99 %)
21 diff
(97.8 %id)
BX410281 adult brain, brain .vf 947 to 1863 1 to 913       913/913
(100 %)
26 diff
(97.2 %id)
BX445430 adult brain, brain .vf 1139 to 2192 1042 to 1       1042/1118
(93 %)
34 diff
(97.0 %id)
BX453149 brain, fetal brain .vf 1378 to 2165 777 to 1       777/854
(90 %)
37 diff
(95.7 %id)
BX411169 adult brain, brain .vf 1440 to 2225 788 to 6       783/788
(99 %)
0 diff
(100 %id)
BX413174 brain, fetal brain .vf 1483 to 2225 745 to 1       745/904
(82 %)
17 diff
(98.2 %id)
CK004724 brain/CNS, Human Brain - Frontal Cortex .vf 1531 to 2165 1 to 635       635/635
(100 %)
7 diff
(98.9 %id)
BF848555 lung_normal .vf 1542 to 1718 177 to 1     Submitted on the opposite strand 177/177
(100 %)
1 diff
(99.5 %id)
BU630279 cell lines, Chondrosarcoma .vf 1627 to 2234 626 to 19   AAA   608/620
(98 %)
0 diff
(100 %id)
DB318185   .vf 1654 to 2228 575 to 1       575/575
(100 %)
1 diff
(99.9 %id)
DB347278 kidney, tumor tissue .vf 1726 to 2234 509 to 1       509/509
(100 %)
4 diff
(99.3 %id)
DB574858 hypothalamus .vf 1761 to 2227 1 to 467     Submitted on the opposite strand 467/468
(99 %)
1 diff
(99.8 %id)
F22504 pectoral muscle (after mastectomy) .vf 1838 to 2220 1 to 379   AAA   379/379
(100 %)
6 diff
(98.5 %id)
F33448 pectoral muscle (after mastectomy) .vf 1978 to 2237 1 to 260   tiling clone,   260/261
(99 %)
4 diff
(98.5 %id)
F32387 pectoral muscle (after mastectomy) .vf 1992 to 2227 23 to 258       236/258
(91 %)
6 diff
(97.7 %id)
AW341989 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .vf 2000 to 2228 229 to 1       229/229
(100 %)
0 diff
(100 %id)
CB152043 brain .vg 1 to 568 1 to 568 Y158C tiling clone,   568/568
(100 %)
5 diff
(99.2 %id)
BX371046 Placenta Cot 25-normalized .vh 1 to 905 1 to 903   tiling clone,   903/903
(100 %)
8 diff
(99.2 %id)
DB209458 trachea .vh 394 to 898 2 to 508   capped   507/507
(100 %)
8 diff
(98.5 %id)
DA278625 corpus callosum .vh 407 to 958 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
AK307421   .vh 457 to 1400 1 to 944 exact tiling clone,   944/944
(100 %)
0 diff
(100 %id)
DA029078   .vh 458 to 1026 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
BX326938   .vh 1382 to 1741 1 to 359   tiling clone,   359/359
(100 %)
18 diff
(95.0 %id)
BY994065   .vh 1703 to 2379 18 to 694   tiling clone,   677/694
(97 %)
6 diff
(99.2 %id)
BX362688   .vh 1724 to 2494 793 to 22       772/851
(90 %)
0 diff
(100 %id)
BQ019274 lung, Metastatic Chondrosarcoma .vh 1832 to 2536 720 to 19   tiling clone, AAA   702/702
(100 %)
7 diff
(99.1 %id)
BX363536   .vi 1 to 987 1 to 972   tiling clone,   972/972
(100 %)
19 diff
(98.1 %id)
CR603106 HeLa cells Cot 25-normalized .vi 52 to 2070 1 to 2019 exact tiling clone,   2019/2019
(100 %)
0 diff
(100 %id)
BX341532   .vi 52 to 938 1 to 884       884/891
(99 %)
12 diff
(98.7 %id)
BM907071 brain, hippocampus .vi 457 to 1337 6 to 891       889/1014
(87 %)
21 diff
(98.0 %id)
BX328713 Placenta Cot 25-normalized .vi 458 to 1335 1 to 875       875/875
(100 %)
28 diff
(96.8 %id)
BX337375 Placenta Cot 25-normalized .vi 464 to 1243 1 to 776       776/780
(99 %)
43 diff
(94.5 %id)
BX408976 neuroblastoma .vi 655 to 1406 752 to 1       752/869
(86 %)
15 diff
(98.3 %id)
BX326709   .vi 655 to 1245 606 to 16       591/675
(87 %)
14 diff
(98.0 %id)
BX368939   .vi 730 to 1064 1 to 335       335/374
(89 %)
11 diff
(97.1 %id)
CR597558 neuroblastoma .vj 1 to 1782 4 to 1785 exact tiling clone,   1785/1785
(100 %)
0 diff
(100 %id)
BX403812 neuroblastoma .vj 44 to 1028 1 to 978       978/978
(100 %)
25 diff
(97.5 %id)
BX428237 neuroblastoma .vj 46 to 955 49 to 956       908/956
(94 %)
12 diff
(98.8 %id)
DA909121   .vj 63 to 622 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
TI_57149442   .vk 1 to 898 25 to 917 exact tiling clone,   893/955
(93 %)
18 diff
(98.2 %id)
BI759439 pooled colon, kidney, stomach .vk 9 to 898 1 to 885 exact tiling clone,   885/923
(95 %)
12 diff
(98.7 %id)
AA522438 colon .vk 855 to 1437 582 to 1   tiling clone,   582/582
(100 %)
6 diff
(99.0 %id)
AW970650   .vk 868 to 1471 610 to 7   tiling clone, Submitted on the opposite strand 604/610
(99 %)
2 diff
(99.7 %id)
BE908376 epithelioid carcinoma, Pancreas .vl 1 to 551 1 to 552 exact tiling clone,   552/552
(100 %)
1 diff
(99.9 %id)
BQ068329 brain .vm 1 to 627 1 to 629   tiling clone,   629/1236
(50 %)
5 diff
(99.6 %id)
TI_57196006   .vm 2 to 700 27 to 727       701/835
(83 %)
17 diff
(98.0 %id)
BI818226 pooled brain, lung, testis .vm 7 to 700 1 to 696       696/804
(86 %)
13 diff
(98.4 %id)
CN301617 embryonic stem cells, DMSO-treated H9 cellline .vm 24 to 623 1 to 600       600/600
(100 %)
2 diff
(99.7 %id)
TI_57240627   .vm 54 to 735 29 to 744       716/750
(95 %)
30 diff
(96.0 %id)
BI914035 brain .vm 58 to 735 1 to 712       712/718
(99 %)
43 diff
(94.1 %id)
BM921012 pooled brain, lung, testis .vm 104 to 1023 11 to 957   tiling clone,   944/1074
(87 %)
43 diff
(96.0 %id)
DB474674 hippocampus .vm 105 to 612 1 to 508       508/517
(98 %)
6 diff
(98.9 %id)
BM547119 brain, hippocampus .vm 142 to 833 20 to 716       697/1160
(60 %)
32 diff
(97.3 %id)
BM151910 leukopheresis .vm 143 to 682 1 to 540   tiling clone,   540/541
(99 %)
13 diff
(97.6 %id)
BX328444 Neuroblastoma Cot 25-normalized .vm 155 to 695 1 to 542       542/725
(74 %)
19 diff
(97.4 %id)
BI911556 leukocyte .vm 169 to 761 30 to 623       594/626
(94 %)
12 diff
(98.1 %id)
TI_57232906   .vm 169 to 761 30 to 623       594/626
(94 %)
12 diff
(98.1 %id)
CT005055 T-Lymphocytes .vm 189 to 875 1 to 687   tiling clone,   687/687
(100 %)
1 diff
(99.9 %id)
BM543591 brain, hippocampus .vm 234 to 823 1 to 592       592/1115
(53 %)
16 diff
(98.6 %id)
BU584896 esophagus .vm 297 to 830 1 to 539       539/539
(100 %)
7 diff
(98.8 %id)
CN301616 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .vm 964 to 1631 1 to 668   tiling clone,   668/668
(100 %)
0 diff
(100 %id)
BI668476 brain, hypothalamus .vn 1 to 780 1 to 779 R123G C165G tiling clone,   779/779
(100 %)
19 diff
(97.6 %id)
TI_44344647   .vn 5 to 780 81 to 855       775/855
(90 %)
20 diff
(97.7 %id)
BP355213   .vn 58 to 640 1 to 583   tiling clone,   583/583
(100 %)
2 diff
(99.7 %id)
BP355216   .vn 65 to 638 1 to 582       589/582
(101 %)
32 diff
(94.6 %id)
AA379028 synovial membrane .vo 1 to 332 1 to 335   tiling clone,   335/335
(100 %)
4 diff
(98.9 %id)
AW958342   .vo 2 to 618 1 to 618       618/619
(99 %)
17 diff
(97.3 %id)
DR006755 Spleen .vo 89 to 656 7 to 574   tiling clone,   568/574
(98 %)
3 diff
(99.5 %id)
BM923562 pooled colon, kidney, stomach .vo 613 to 1286 1 to 674   tiling clone,   983/1024
(95 %)
30 diff
(97.1 %id)
BI820100 pooled brain, lung, testis .vp 1 to 849 1 to 855 P124A S126F H127T S128Q C129L ... tiling clone,   815/859
(94 %)
16 diff
(98.2 %id)
TI_57199810   .vp 1 to 849 60 to 914 P124A S126F H127T S128Q C129L ...     855/918
(93 %)
21 diff
(97.8 %id)
AK098058 kidney, tumor tissue .vq 1 to 1172 2 to 1173 C128R P133L D139N tiling clone, available from FLJ,   2760/2760
(100 %)
15 diff
(99.5 %id)
DB170263 kidney, tumor tissue .vq 1 to 459 2 to 460   capped   459/459
(100 %)
1 diff
(99.8 %id)
AK123665   .vq 410 to 1172 1 to 763 C128R P133L D139N available from FLJ,   2344/2344
(100 %)
15 diff
(99.4 %id)
DA543841   .vq 411 to 985 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
BQ068295 brain .vr 1 to 618 69 to 695   tiling clone,   627/1432
(43 %)
19 diff
(98.7 %id)
DB636633 hypothalamus .vr 1133 to 1292 1 to 160   tiling clone,   160/160
(100 %)
1 diff
(99.4 %id)
BI906423 leukocyte .vr 1272 to 1356 1 to 85   tiling clone,   85/85
(100 %)
3 diff
(96.5 %id)
TI_57232375   .vr 1272 to 1992 29 to 752   tiling clone,   724/752
(96 %)
12 diff
(98.5 %id)
CR988190 T-Lymphocytes .vr 1815 to 2529 1 to 715   tiling clone,   715/715
(100 %)
2 diff
(99.8 %id)
DA528923 brain .vs 1 to 495 4 to 498 P36R G38R V64I G88A tiling clone, capped   497/497
(100 %)
4 diff
(99.2 %id)
AK308768 amygdala .vt 1 to 944 2 to 945 exact tiling clone,   945/945
(100 %)
3 diff
(99.7 %id)
DA191733 amygdala .vt 1 to 577 2 to 581 A25C V26R Y27V R28P D29G ... capped   578/580
(99 %)
4 diff
(99.4 %id)
DA191772 amygdala .vt 1 to 604 2 to 605 exact capped   604/604
(100 %)
1 diff
(99.9 %id)
CX762194 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .vu 1 to 707 1 to 702 C56R G88V tiling clone, Submitted on the opposite strand 702/703
(99 %)
13 diff
(98.2 %id)
AK289770 brain .vv 1 to 1423 6 to 1428 exact tiling clone,   1428/1428
(100 %)
1 diff
(100.0 %id)
DA224941 brain .vv 1 to 510 6 to 515   capped   514/514
(100 %)
1 diff
(99.9 %id)
TI_57240387   .vw 1 to 891 36 to 933 G19V Q20T L21A D22G R23P ... tiling clone,   898/933
(96 %)
34 diff
(96.4 %id)
BI913200 brain .vw 7 to 722 1 to 716   tiling clone,   716/892
(80 %)
14 diff
(98.5 %id)
CR990532 T-Lymphocytes .vx 1 to 469 1 to 470 exact tiling clone,   470/470
(100 %)
1 diff
(99.8 %id)
BI438929 Pancreas, Purified pancreatic islet Gene MAPK12andHDAC10, variant not shown         Suspected internal deletion, this clone was ignored    
BX346476 Neuroblastoma Cot 25-normalized Gene MAPK12andHDAC10, variant not shown         This clone was ignored    
DB479494 hippocampus Gene MAPK12andHDAC10, variant not shown         Suspected internal deletion, this clone was ignored    
AA613434 colon, colon tumor RER+ Gene MAPK12andHDAC10, variant not shown         Suspected internal deletion, this clone was ignored    
BG163305 hypernephroma, cell line, Kidney Gene MAPK12andHDAC10, variant not shown         Suspected internal deletion, this clone was ignored    
BI757984 brain Gene MAPK12andHDAC10, variant not shown         Suspected internal deletion, this clone was ignored    
TI_57221497   Gene MAPK12andHDAC10, variant not shown         Suspected internal deletion, this clone was ignored    
DA653839   Gene MAPK12andHDAC10, variant not shown       capped Suspected internal deletion, this clone was ignored    
DC397711 testis Gene MAPK12andHDAC10, variant not shown         Suspected internal deletion, this clone was ignored    
TI_154124825   Gene MAPK12andHDAC10, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf, .vg, .vh, .vi, .vj, .vk, .vl, .vm, .vn, .vo, .vp, .vq, .vr, .vs, .vt, .vu, .vv, .vw, .vx Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI